amador bioscience-png

Clinical Pharmacology for Cohesive Research Programs

The pharmacological development of your nonclinical and clinical projects is focused, faster, and more efficient in our care. We apply advanced simulation and modeling to optimize the safety and efficacy of your trial.

Talk to an Expert
Noncompartmental PK/TK Analysis & Reporting NCA is critical to characterize your drug early and efficiently. Translational Modeling and Simulation Take an early-phase focus on opportunities for development. Toxicokinetics

Get help with ADME characterization.
Population Pharmacokinetics Detailed compartmental methods to help with later phases. Clinical Modeling and Simulation Simulate to optimize your trial design and output. Consulting Use our extensive experience to make a better project.

How Can We Help?

Learn how we can help you make informed decisions about your clinical program. Our team of scientists provides the data and expertise you need to meet regulatory standards and make go/no-go decisions faster.

Let's Get Started

Accelerate your Drug Development by Leveraging Our Years of Experience

With our adaptive and detailed clinical pharmacology studies, you can rely on our team's expertise to help you obtain pivotal data that impacts the success of your drug development program. Our streamlined process also ensures an efficient start to even the most complex studies.



AdvancedSimulation_551x402@2x Advanced Modeling and Simulation The FDA and EMA prioritize simulation and modeling as part of the drug development process. We use our technologies and team experience to create efficiencies that minimize and sometimes even eliminate the need to complete some clinical studies, as well as for making decisions on marketing submissions. Website Photos (6) Global Drug Development and Launch We give you the advantage of entry to the US, Chinese, European, and emerging markets. With local representation you'll get the best out of your investment and optimally navigate region-specific requirements in industry, academic, and regulatory settings.

Have a Question?

It's easy to talk to one of our experts. Get in touch with your questions or comments and a member of our team will get back to you directly.

Talk to an expert